Websol Eyes Full Utilization, TOPCon by March 2027

Websol Energy System Limited — Q1 FY27 Earnings Call (11 Aug 2026; results for quarter ended 30 Jun 2026)

1. Overall Tone of Management: Optimistic

• Management highlights strong operating conversion: “Q1 FY27 is about beginning to convert that base into operating performance.”
• Emphasizes execution and balance-sheet discipline: “repaid the entire INR110 crores… from internal accruals” and “without slowing any of our ongoing growth investments.”
• Forward-looking confidence on utilization and execution: expects “close to full run-rate utilization” and TOPCon upgrade completion by “March 2027.”

2. Key Themes from Management Commentary

• Capacity coming on stream → utilization-led growth
• Cell production: 259 MW vs 126 MW; utilization 92%.
• Module production: 103 MW vs 50 MW; utilization 81%.
• Margin pressure explained by mix (modules vs cells)
• EBITDA margin: 34% vs 47% YoY, attributed to “change in our sales mix… module margins are lower than cell margins.”
• Despite lower % margin, EBITDA grew 21% due to higher absolute volume.
• Capital discipline / balance-sheet strengthening
• “repaid the entire INR110 crores outstanding on our IREDA term loan from internal accruals.”
• Promoter pledge reduced from 80% to 16% (collateral release).
• Technology roadmap: Mono PERC → TOPCon upgrade
• Upgrade of one existing mono PERC cell line to TOPCon: 750 MW TOPCon capacity; overall cell capacity to 1.3 GW with ~55% TOPCon.
• Completion expected by March 2027; capex ~INR270 crores.
• Geographic/expansion narrative: West Bengal as next hub
• Phase 3 expansion location discussion shifts to West Bengal; management cites “constructive… environment” and synergies from Falta ecosystem.
• Reassures: “There is no change in our capex plans… timelines… at this stage.”

3. Q&A Analysis

Theme A: Phase 3 / location shift (Andhra Pradesh → West Bengal) & execution timelines

• Core questions
• Why the location change; impact on timelines, land, machinery lead times, incentives.
• When land approvals and construction would start; whether capex/timelines changed.
• Management response
• Reason: West Bengal environment became “increasingly constructive”; synergies from Falta experience.
• Land: “shortlisted land… awaiting requisite approvals.”
• Timelines: “not anticipating any change… at this stage.”
• Land approval target: “expected… this quarter… hopefully this month.”
• Construction start: “September… mid”; ~9 months to complete; equipment by April–May; trial ~2 months.
• Incentives: cannot disclose until land allocation/approvals.
• Notable / evasive or partial elements
• Incentive comparison (AP vs WB) deferred: “we will be able to disclose only once the land has been allocated.”
• Some questions about “sudden change” were answered with high-level rationale (“execute faster”) rather than detailed decision criteria.

Theme B: Utilization, inventory, pricing dynamics (ALMM impact, inventory build)

• Core questions
• Will they sustain 92% cell and 81% module utilization for FY27?
• Inventory levels: whether MNRE data implies excess inventory; whether it will improve pricing in Q2.
• Current pricing for cells/modules; ALMM effects and demand/supply.
• Management response
• Utilization guidance: 92% “comfortable holding”; module 81% already “close to full effective utilization.”
• Inventory: acknowledged “some increase” but characterized as cyclical; overall inventory up ~7% vs Q4/Q1 comparison; monsoon/offtake slowdown explanation.
• Pricing:
  • Cell realization: “hovering around USD0.13 per watt” (Q1 earlier: ~USD0.125/Wp).
  • Module realization: “INR 20.50–21” (Q1 earlier: ~INR20.50/Wp).
• ALMM: ALMM-2 deferral to December; management links deferral to “cell capacity still remains much lower than module capacity.”
• Notable / unusually strong answers
• Inventory “cyclicality” explanation was detailed (monsoon + production timing + captive cell blocking), which reduced ambiguity.
• Pricing direction: management stated prices are “higher than the previous quarter” despite earlier softness.

Theme C: Margins outlook and drivers (cell vs module mix, silver/BOM)

• Core questions
• Why QoQ EBITDA fell despite higher utilization.
• Whether margin pressure persists for 1–2 years; impact of TOPCon conversion.
• Management response
• QoQ EBITDA decline: “primarily… change in the product mix” plus “realization… softer last quarter” and “increase in BOM cost, particularly silver.”
• Margin durability: “should be able to hold it for a year or two” (cell margins higher; module structurally lower).
• TOPCon margin: incremental revenue/margin benefits discussed qualitatively; exact margin not quantified.
• Notable / evasive elements
• TOPCon payback asked directly: management agreed “payback between 2 to 3 years” and “consider that… less than 3 years if not 2 years,” but still avoided precise EBITDA/margin uplift.

Theme D: Order book quality, targets, and mix (cell vs module)

• Core questions
• Internal targets for order book by FY27.
• Whether order book mix shift indicates stronger cell demand.
• How much cell is sold externally vs captive consumption.
• Management response
• Order book: only “firm purchase orders”; not targeting higher order book size.
• Mix: declined to forecast mix evolution; said mix depends on realization and captive conversion.
• External cell sales: “sold roughly 153 MW to external customers.”
• Notable / partial answers
• Mix forecast for FY27–FY28 was explicitly “difficult to comment,” which limits visibility.

Theme E: Investor relations / valuation / transparency

• Core questions
• Why institutional interest/valuation is low; whether management is not communicating timely.
• Concerns about share price movements and “Phase 3” updates.
• Management response
• Valuation: management claims operations are strong; institutional exposure limited; will increase interactions.
• Transparency: management denies withholding: “not aware of any information… management is not aware of any fraud,” and says they are promptly submitting required disclosures.
• Location-change timing criticism was met with “decision… based on where we could implement… faster” and “synergies,” but did not directly reconcile the “6–8 months” earlier AP planning.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Q1 FY27 results (reported)
• Revenue from operations: INR 373 crores
• EBITDA: INR 126 crores (margin 34%)
• PAT: INR 78 crores
• Utilization
• Cell utilization: 92% “comfortable holding” (near full run-rate expected through year, except TOPCon downtime).
• Module utilization: 81% achieved; expects close to full run-rate.
• Order book
• Confirmed order book: INR 1,278 crores (30 Jun 2026); also referenced INR 1,161 crores earlier in the call for prior quarter context.
• TOPCon upgrade
• Completion: March 2027
• Capex: ~INR 270 crores
• Added capacity: 150 MW additional capacity (upgrade line) and overall 750 MW TOPCon on that line; overall cell capacity to 1.3 GW
• Efficiency expectation: “around 25%” for upgraded facility
• TOPCon payback
• Asked directly: “payback between 2 to 3 years”
• Follow-up: “consider that… less than 3 years if not 2 years”
• Phase 3 (West Bengal) execution signals
• Land approvals: “expected… this quarter… hopefully this month”
• Construction start: “September… mid”
• Trial/equipment timing: equipment by April–May, trial ~2 months

Implicit signals (qualitative)

• Margins
• Management expects margin levels to be maintainable: “hold… for a year or two” (but acknowledges variability).
• Demand
• No demand slowdown for their DCR-linked products: “not seeing any reduction.”
• Industry demand expected to increase due to broader solar/BESS/AI narratives.
• ALMM
• ALMM-2 deferral suggests cell-module capacity mismatch persists; management implies demand support into December.

5. Standout Statements (direct quotes where useful)

• Operating conversion / utilization
• “Q1 FY27 is about beginning to convert that base into operating performance.”
• “cell utilization at 92%” and “module utilization moved… to 81%.”
• Margin explanation
• “EBITDA margin… 34% against 47%… principal reason is the change in our sales mix.”
• Balance-sheet discipline
• “On 4th August, we repaid the entire INR110 crores… from internal accruals.”
• “promoter pledge will accordingly come down from 80% to 16%.”
• Technology execution
• “We expect the upgrade to be completed by March 2027.”
• Phase 3 location rationale
• “West Bengal… entering an interesting phase… encouraging…”
• “There is no change in our capex plans… timelines… at this stage.”
• TOPCon payback
• “payback between 2 to 3 years” and “consider that… less than 3 years if not 2 years.”
• Investor relations / transparency
• “management is not aware of any fraud” and “promptly submitting all the required information.”

6. Red Flags / Positive Signals

Red flags
– Location shift narrative risk: AP → West Bengal change is repeatedly defended as “synergies/execute faster,” but investors challenged “timely updates” and “planning competence.” Management did not provide a detailed reconciliation of the earlier AP timeline beyond rationale.
– Margin guidance remains non-precise: TOPCon margin impact is discussed qualitatively; no quantified EBITDA margin uplift.
– Order book mix forecasting avoided: management says mix evolution is “difficult to comment” due to realization dependence.
– Valuation/IR tension: multiple questions about low institutional interest and share price movements; management response is largely process-based (“increase interactions”) rather than addressing valuation drivers.

Positive signals
– Strong operational execution: utilization and production ramp are concrete and quantified.
– Balance-sheet improvement: full IREDA loan repayment from internal accruals; pledge reduction is a tangible de-risking event.
– Demand confidence for DCR-linked products: management explicitly states no demand reduction for their product profile.
– Clear ALMM interpretation: ties deferral to cell-module capacity mismatch.

7. Historical Comparison & Consistency Analysis (vs prior calls)

a. Change in Tone Over Time

• Current call (Q1 FY27): More Optimistic
• Strong emphasis on “operating performance” conversion and debt repayment.
• Prior call (Q4 & FY26, 28 Apr 2026): Optimistic
• Management already framed FY26 as “landmark” with record margins and cash generation.
• Shift classification: More Optimistic
• Current call adds stronger “capital discipline” proof (loan repaid) and higher utilization/more module integration already underway.

b. Tracking Past Commitments vs Outcomes

• IREDA pledge repayment timeline
• Past statement (Apr 28, 2026): repayment/release expected “in the next month or two.”
• What happened (Aug 11, 2026 call): repaid on 4 Aug 2026; pledge release formalities in progress.
• Assessment: ✅ Delivered (timing broadly aligned; release still “formalities” but repayment done).
• TOPCon upgrade timeline (600 MW line → TOPCon)
• Past statement (Apr 28, 2026): commercial start expected by Feb 2027; ramp-up ~2 months.
• Current statement: upgrade completion by March 2027 (slightly later than Feb but close).
• Assessment: ⏳ Slightly delayed (Feb → March; not a major miss but a shift).
• Phase 3 (AP) execution timeline
• Past statement (Apr 28, 2026): Phase 3 details to be shared; commitment “on track”; earlier AP location discussed in Q&A.
• Current statement: Phase 3 location shifted to West Bengal; land approvals targeted “this quarter.”
• Assessment: ❌ Dropped/changed narrative (location change is a material deviation; management insists timelines unchanged, but investors flagged earlier planning duration).

c. Narrative Shifts

• AP expansion narrative replaced by West Bengal
• Earlier calls referenced Andhra Pradesh evaluation; now West Bengal is positioned as the “natural place” for next capacity.
• Margin narrative remains consistent in mechanism but changes in magnitude
• Prior call: margin compression explained by module introduction and silver/BOM.
• Current call: same mechanism, but now explicitly tied to module-heavy sales mix and utilization ramp.
• IR/valuation topic emerges more forcefully
• Current call includes direct confrontations about institutional interest and share price transparency—less prominent in the earlier transcript.

d. Consistency & Credibility Signals

• Medium credibility
• Positives: concrete execution metrics (utilization, production, debt repayment) support credibility.
• Concerns: repeated deferrals/avoidance on sensitive topics (incentives disclosure, TOPCon margin quantification, Phase 3 incentive parity, mix forecasting). Location shift triggered investor skepticism about planning/timeliness.

e. Evolution of Key Themes

• Demand: Stable/positive (management consistently says DCR-linked demand is intact; ALMM supports).
• Margins: Deterioration in % margin continues (34% vs 47% YoY), but management consistently attributes to mix and input costs—no new structural deterioration claim.
• Expansion strategy: Pivot in geography (AP → WB) while claiming no change in capex/timelines.
• Technology: TOPCon remains central; now also framed as a bridge to future 4 GW scale.

f. Additional Insights (cross-period intelligence)

• ALMM deferral is being used as a demand-support argument while simultaneously implying cell capacity still lags module capacity—this supports management’s pricing optimism, but also signals that the industry’s structural mismatch may persist longer than investors expect.
• Inventory explanations are becoming more operationally grounded (monsoon/offtake + production timing + captive cell blocking), suggesting management is learning to pre-empt margin/inventory concerns with clearer causality.